Stayble Therapeutics appoints Lago Kapital AB as liquidity provider
Stayble Therapeutics AB (“Stayble” or “the Company”) has entered into a liquidity providing agreement with Lago Kapital AB. Stayble has terminated its existing liquidity providing agreement with Mangold Fondkommission AB. The liquidity providing agreement with Lago Kapital AB will be effective starting on May 9th, 2022.Lago Kapital AB will provide liquidity according to Nasdaq Stockholm rules set-out for liquidity providing. The intention is to promote liquidity in the share. The agreement will be in force initially for a fixed term of six (6) months and thereafter until further notice with